Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism LOXL2 inhibitors(Lysyl oxidase homolog 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Liver Cirrhosis | Phase 1 | - | - | |
Pulmonary Fibrosis | Phase 1 | - | - | |
Renal fibrosis | Phase 1 | - | - | |
Idiopathic Pulmonary Fibrosis | Discovery | AU | 14 Dec 2017 | |
Neoplasms | Discovery | AU | - | |
Nonalcoholic Steatohepatitis | Discovery | AU | - |